Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Otsuka Holdings Co., Ltd.

http://www.otsuka.com/en/

Latest From Otsuka Holdings Co., Ltd.

Tech Transfer Roundup: Oncology Deals Focus On CAR-T Innovations, ADCs, DNA Damage Response

Cancer deals involve City of Hope/Chimeric, CARISMA/NYU, Sorrento/Mayo Clinic, Rain/Drexel, Diaprost/Memorial Sloan Kettering, Alkido/University of Kentucky. Plus, research collaborations in brief.

Deals Research and Development Strategies

Vitafusion ‘Clinically Proven Absorption’ Claim Fails In C&D Appeal Of Industry Self-Regulation Review

Church & Dwight will comply with National Advertising Review Board decision to discontinue claim for vitafusion supplements. The panel rejected C&D’s argument that any amount of vitamin absorption is “clinically meaningful” and deferred to the National Advertising Division on C&D’s procedural challenge.

Enforcement Dietary Supplements

Digital Therapeutics Have Arrived But Will Insurers Get On Board?

Will FDA-cleared prescription digital therapeutics be able to follow wellness, chronic disease and sleep disorder apps onto the formularies of major payers? For digital therapeutics companies investing in randomized controlled clinical trials, GMP manufacturing and FDA submissions for products, the current absence of public health insurance coverage is frustrating.

Digital Health Government Payers

Stacked User Fee Calendar Puts Another Record-Setting Year For US FDA Novel Approvals Within Reach

With goal dates for almost 40 novel drugs and biologics coming up in the second half of 2020 after a record number of first half approvals, even the pandemic looks unlikely to prevent another solid year for innovative drugs at US FDA.

Drug Review Review Pathway
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Alamo Pharmaceuticals, LLC
    • Astex Pharmaceuticals, Inc.
    • Avanir Pharmaceuticals, Inc.
    • Daiya Foods Inc.
    • Diatranz Otsuka Limited
    • JIMRO Co., Ltd.
    • Korea Otsuka Pharmaceutical Co., Ltd.
    • Mitsui & Co., Ltd
    • Montigen Pharmaceuticals
    • Neurovance, Inc.
    • Otsuka Australia Pharmaceutical Pty Ltd
    • Otsuka Pharmaceutical Factory, Inc.
    • Otsuka Medical Devices Co., Ltd.
    • Otsuka Pharmaceutical Co., Ltd
    • Otsuka Pharmaceutical India Private Limited
    • ReCor Medical, Inc.
    • Singapore Otsuka Pharmaceutical Co., Ltd.
    • SuperGen, Inc.
    • Taiwan Otsuka Pharmaceutical Co., Ltd.
    • Taiho Pharmaceutical Co., Ltd.
    • Taiho Pharma Canada, Inc.
    • Visterra Inc.
UsernamePublicRestriction

Register